14th Laboratory Informatics Summit | International Quality & Productivity Center | 26 June 2017 | Philadelphia, Pennsylvania

The discovery-to-market journey is now more complex and expensive than ever before

There is an explosion of knowledge happening in pharma, but even with a slew of technological and scientific advances, how are we not witnessing a more productive R&D landscape? The cost of enduring R&D is higher than ever before, yet productivity across the industry has gone flat. This frontier has an incredible degree of complexity, and there’s no defined path or platform towards complete data integration, harmonization, and accessibility.

Carmen Nitsche
Executive Director Business Development North America
Pistoia Alliance

Peter Gates
Director Data Architecture Translational Informatics
Janssen, Pharmaceutical Companies of Johnson and Johnson

Farida Kopti
Director, MRL IT
Merck

Robert J Boland
Associate Director, Emerging Science & Innovation
Johnson & Johnson

Mark Weiner
Assistant Dean for Informatics
Temple University

James Gill
Director, Research Analytics
Bristol-Myers Squibb

Eduardo Zaborowski, Ph.D
Senior Director, Information and Research Technologies
The Jackson Laboratory

Adam Fermier
Scientific Director
Johnson & Johnson

Anthony Donofrio
Senior Scientist, HTE and Lead Discovery Capabilities
Merck Research Laboratories

Alison Harkins
Engineer
Janssen

Nathan McBride
Senior Vice President & CIO, Innovation Architects
AMAG Pharmaceuticals

Cindy Novak
Mgr I, IT
Shire

Viral Vyas
Associate Director, R&D IT
Bristol-Myers Squibb

Sujata Pandey
Manager, Technical Operations IT
Shire

Allan M Ferguson
Senior Director, MRL IT
Merck

Bruce Kozuma
Principle System Analyst
The Broad Institute

Scott Harrison
Associate Principal Scientist, Cheminformatics
Merck

Steven Mehrman
Principal Scientist
Janssen

No indicate event sponsors in their website.